The Prevalence of Premonitory Symptoms in Paediatric Migraine: A Questionnaire Study in 103 Children and Adolescents

Jc, Cuvellier; A, Mars; Vallée, Louis

doi:10.1111/j.1468-2982.2009.01854.x

Cited by 78 publications

(96 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Two authors (SG and GB) read the title and abstract of every identified study and critically appraised the full text of potentially eligible studies. Table 1 summarizes the studies of prodrome reported in children and adults with migraines [4][5][6][7][8][9][10][11]. Our search reveals no devoted studies to the diagnostic and therapeutic significance of preictal symptomatology in migraines.…”

Section: Methods Literature Searchmentioning

confidence: 99%

Preictal Symptomatology in Migraines: Diagnostic and Therapeutic Significance

Gupta¹,

Gupta²

2015

Journal of Headache &Amp; Pain Management

View full text Add to dashboard Cite

Prodrome and aura constitute preictal symptomatology of migraines. The objective of this clinical review is to examine the diagnostic and therapeutic significance of preictal symptomatology in children with migraines. The systemic review of the literature identified a single study in children with migraines. The majority studies were in adults. Based on our search and longitudinal clinical observation, we describe the clinical characteristics of diagnostic and therapeutic significance of preictal symptoms and various types of auras in migraines. Such significance can be substantially increased by including prodromal physical signs in children with migraines. Future studies' methodology should include physical signs in addition to symptoms and identify the spectrum of the various auras, and relate to their temporal association with ictal and postictal phases of migraines. In addition these clinical parameters should be statistically analyzed.

show abstract

Section: Methods Literature Searchmentioning

confidence: 99%

Preictal Symptomatology in Migraines: Diagnostic and Therapeutic Significance

Gupta¹,

Gupta²

2015

Journal of Headache &Amp; Pain Management

View full text Add to dashboard Cite

show abstract

“…[8][9][10][11][12][13] In addition, the majority of the studies performed so far have only looked at symptoms starting before the prevalence rates of 9-88%. 3,[8][9][10][11][12][13][14][15][16][17][18] See Table 1 for a breakdown of studies to date in the literature looking at premonitory symptom prevalence.…”

Section: Prevalence Of Premonitory-like Symptoms In Migrainementioning

confidence: 99%

Section: Prevalence Of Premonitory-like Symptoms In Migrainementioning

confidence: 99%

“…17,18 One of these showed a prevalence of 67% in the cohort of 103 children and adolescents with migraine. 18 The other study preselected patients who had reported at least one premonitory symptom. 17 These studies highlight consistently the presence of these symptoms among migraineurs and their ability to predict impending headache, as well as their presence or development at any time during a migraine attack.…”

Section: Prevalence Of Premonitory-like Symptoms In Migrainementioning

confidence: 99%

“…Paediatric studies have shown that the phenotype in children and adolescents is mostly comparable to that in adults. 17,18 Relationship of symptoms to the neurobiology of migraine…”

Section: Phenotype Of Premonitory-like Symptomsmentioning

confidence: 99%

See 2 more Smart Citations

Premonitory-like Symptomatology in Migraine

Karsan

Goadsby²

2017

European Neurological Review

View full text Add to dashboard Cite

It has been historically accepted that migraine involves symptomatology outside of head pain. These symptoms can be as equally disabling as the pain, and can include tiredness, concentration impairment, memory impairment and mood change. The symptoms may start before the onset of pain and can persist throughout the headache phase, and even after effective headache treatment into the postdrome. Despite knowledge of these symptoms, their neurobiologic basis and relationship to migraine pain is poorly understood. The fact that these symptoms start early, up to hours to days before the onset of headache, and are so symptomatically heterogeneous, suggests that the neurobiology of migraine extends beyond conventionally accepted anatomical pain areas within the brain -what has been known as the pain matrix or network. In a research area where no effective acute abortive drugs have gained a license for migraine since the triptans (serotonin 5-HT 1B/1D receptor agonists), in the 1990s, further understanding of such symptomatology will allow therapeutic advances for treatments that may work before the onset of migraine pain and thus prevent it. This review will outline our current understanding about the phenotype and neurobiology of the premonitory (prodromal) symptoms, which for the purpose of this review will be called 'premonitorylike', given they can start before or during pain. Symptoms starting after pain resolution (postdromal symptoms) will not be covered here. KeywordsMigraine, premonitory, prodrome, functional imaging Disclosure: Nazia Karsan is an Association of British Neurologists/Guarantors of Brain Clinical Research Training Fellow. Peter J Goadsby reports personal fees from Allergan, Amgen, and Eli-Lilly and Company; and personal fees from Akita Biomedical, Alder Biopharmaceuticals, Autonomic Technologies Inc., Avanir Pharma, Cipla Ltd, CoLucid Pharmaceuticals Inc., Dr Reddy's Laboratories, eNeura, ElectroCore LLC, Novartis, Pfizer Inc., Promius Pharma, Quest Diagnostics, Scion, Teva Pharmaceuticals, Trigemina Inc., Scion; and personal fees from MedicoLegal work, Journal Watch, Up-to-Date, Oxford University Press; in addition, Peter J Goadsby has a magnetic stimulation for headache patent pending assigned to eNeura. No funding was received for the publication of this article. Peter J Goadsby is a member of the European Neurological Review Editorial Board. Compliance with Ethics:This study involves a review of the literature and did not involve any studies with human or animal subjects performed by any of the authors.Authorship: All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this manuscript, take responsibility for the integrity of the work as a whole and have given final approval for the version to be published.Open Access: This article is published under the Creative Commons Attribution Noncommercial License, which permits any non-commercial use, distribution, adaptation, and reproduction provided the original author(s) and source are giv...

show abstract

Can We Really Stop Pediatric Migraine?

Zernikow

2020

JAMA Pediatr

View full text Add to dashboard Cite

Pediatric primary headache is one of the leading health care issues in high-income countries that is rising in prevalence. 1 Frequent headaches are strongly associated with a lower quality of life and poorer academic performance and are a leading cause of school absence. 2 The classification system of the International Headache Society provides a navigation system to phenomenologically diagnose migraines, tension-type headaches, and other primary headaches (http://www.ihs-classification.org/_downloads/mixed/ International-Headache-Classification-III-ICHD-III-2013-Beta. pdf); however, pediatric-specific factors have not been considered sufficiently. 3 A migraine is not just a headache-it is a complex neurological condition. More than 60% of children with migraine display a premonitory phase before the migraine attack. It is characterized by various symptoms, such as pallor or shadows under the eyes, fatigue, irritability, anxiety, phonophobia, yawning, photophobia, nausea, and, less commonly, concentration problems, food craving, cacosmia, hyperactivity, stiff neck, neck pain, sadness, and sleep problems. 4 More than 50% of children with migraine show cranial autonomic symptoms, such as a red ear, facial flushing, conjunctival injection, lacrimation, nasal obstruction, facial sweating, ptosis, yawning, rhinorrhea, eyelid edema, or miosis. The cranial symptoms are bilateral in 70% of cases. 5 A migraine attack may also be accompanied by other autonomic symptoms (nausea, vomiting, frequent urination, and diarrhea), affective symptoms (depression and irritability), cognitive symptoms (eg, attention deficit, difficulty finding words, or transient amnesia), and sensory symptoms (photophobia, phonophobia, osmophobia, and cutaneous allodynia). 6 Patients with migraine, especially those with migraine with aura, more often experience various transient sensory and neuropsychological symptoms like visual illusions (eg, autokinesis, corona phenomenon, cinematographic vision, double vision, metamorphopsia, visual splitting, dyschromatopsia, and illusionary visual spread) or complex higher cortical dysfunctions (altered perception of body size, weight, or position in space). 7 Therefore, a useful rule for pediatricians and pediatric neurologists is to believe a child with a migraine who tells you strange stories.Some key differences between children and adults in migraine presentation are evident. For example, during the migraine attack, children often show bifrontal or bitemporal pain instead of the clear pain laterization reported in adults. Additionally, the migraine attack duration in children can be shorter than in adults, for whom it typically lasts many hours. 3 Fur-

show abstract

The Prevalence of Premonitory Symptoms in Paediatric Migraine: A Questionnaire Study in 103 Children and Adolescents

Cited by 78 publications

References 15 publications

Preictal Symptomatology in Migraines: Diagnostic and Therapeutic Significance

Preictal Symptomatology in Migraines: Diagnostic and Therapeutic Significance

Premonitory-like Symptomatology in Migraine

Can We Really Stop Pediatric Migraine?

Contact Info

Product

Resources

About